Latest

ESMO Spotlight: James Campbell, Merck KGaA, Darmstadt, Germany

As this year's ESMO gets under way, Pharm Exec spoke to James Campbell—global franchise business head at Merck KGaA, Darmstadt, Germany—to discuss his vision for the company as a global leader in oncology.

Pharm Exec's Emerging Pharma Leaders 2018

Pharm Exec’s 11th annual list profiles the diverse stories of 10 rising biopharma managers—and how each are changing the ways leaders direct critical industry functions.

Lead Across Borders: How to Maximize the Value of Your International Alliance

Eli Lilly's Michael W. Magdycz share some of the lessons he's learned directing alliances spanning a range of countries and products.

Choosing the Right Track: Pharma & Healthcare MBAs

A growing range of MBAs with concentrations in pharmaceuticals and healthcare management are on offer. Pharm Exec look at how three of the top programs in the US prepare their students for industry success.

Pharm Exec Video

Behind the Scenes with Kallyope’s Nancy Thornberry

A sneak peek at Pharm Exec's August cover shoot with the New York City-based biotech CEO.

Why One Korean Biotech Picked New Jersey for U.S. Headquarters

New Jersey is still a top pick for companies when it comes to pharma.

Pharm Exec Talks Partnerships with Sanofi

Hear what Sanofi looks for when they decide to form a partnership with another company.

New & Noteworthy

Vienna’s Vision on Health Regulation in Europe

What will come out of Austria’s shakeup of European pharma rules? Reflector reports.

Four Challenges Preventing AI Reaching Its Full Potential

AI has become ubiquitous but it is also attracting some concerns—around job losses, ethics, and more broadly, how successful it really is, writes Steve Arlington.

What the Age of Multi-Localism Means for Pharma

New realities are transforming the global environment and upending a business model based on the presumption of ever more connected markets. Paul A. Laudicina asks, What does this mean for pharma?

Sales & Marketing

Social Science Behavior Change Models: The Key to More Targeted Messages

Charles Daramola discusses the application of social science behavior change theories and models to physician sales.

Why Your Advertising Agency Should Be Your Analytics Partner

Brands should look to their agencies to be a true data-driven business partner, not just a creative partner, writes Kevin Troyanos.

Learning, Retaining, Applying Information: Preparing Reps for Success in the Field

The most effective way to train sales reps and boost their success is to consider the learner/user experience in all facets, in every training encounter, and on each training platform, writes Shaun McMahon.

eBooks

Emerging BioPharma: Your Guide to Clinical and Commercial Considerations

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways. 

View all eBooks

PEspeaks

Politics Drives DTC Price Disclosure Rule

In publishing its proposed rule on disclosing drug prices just three weeks before the mid-term Congressional elections, it’s not a big stretch to see the move by the Trump administration as designed for short-term political purposes.

The Genetic Data Gold Rush: Balancing Privacy and Health Outcomes

As pharm execs look to real-world data to aid in translational research and close the gap from traditional clinical trials to real-world efficacy, there are three foundational pillars to build from. Bill Fox reports.

Getting Where You Need to Go

As this year's installment of our Emerging Pharma Leaders shows, the current roadmap for a career in biopharma requires its own "Waze"-like navigation.

Crash Course in Strategy

New life sciences internship program has high-level mission. Michelle Maskaly reports.

Interviews

ESMO Spotlight: James Campbell, Merck KGaA, Darmstadt, Germany

As this year's ESMO gets under way, Pharm Exec spoke to James Campbell—global franchise business head at Merck KGaA, Darmstadt, Germany—to discuss his vision for the company as a global leader in oncology.

The Path to Pioneership: Dr. J. Joseph Kim, Inovio Pharmaceuticals

Pharm Exec speaks to Inovio Pharmaceuticals' Dr. J. Joseph Kim about his journey from humble beginnings as an 11-year-old Korean immigrant to his present position at the forefront of a new medical frontier.

Paul Perreault: The Global CEO

Pharm Exec talks with CSL's top executive about the realities of running the global, Australian-headquartered specialty biotech company and sustaining a strong focus in a fast-encroaching era of disruptive technologies and new priorities in innovation and R&D.

Regulatory

Politics Drives DTC Price Disclosure Rule

In publishing its proposed rule on disclosing drug prices just three weeks before the mid-term Congressional elections, it’s not a big stretch to see the move by the Trump administration as designed for short-term political purposes.

Does Being an Orphan Speed Up FDA Approval?

Leela Barham looks at whether FDA approval is expedited when a drug not only secures one or more of the FDA’s expedited development and review methods, but is also when it is designated an orphan drug.

Big Companies Driving FDA Fast Lanes

Use of FDA's options for speedier approval applied to more than half of novel drug approvals in recent years. But which drugs–and from which companies–are being approved faster? Leela Barham reports.

Congressional Action Alters FDA Policies, Pharma Practices

Congress approves bills with provisions important to FDA and industry, some of which reflect continuing concerns about drug pricing and transparency.

From the Editor

Getting Where You Need to Go

As this year's installment of our Emerging Pharma Leaders shows, the current roadmap for a career in biopharma requires its own "Waze"-like navigation.

Specialty Supply Chain Decisions

In today’s drug development environment, there is no doubt that supply chain decisions are paramount in a product launch strategy, writes Lisa Henderson.

lorem ipsum